Abstract：ObjectiveTo explore the effect of Shexiang Baoxin Pills combined with Ligustrazine in the treatment of acute exacerbation of chronic pulmonary heart disease.MethodsFrom June 2016 to May 2017,100 patients with acute exacerbation of chronic pulmonary heart disease were selected as subjects and randomly divided into four groups(A,B,C and D,respectively)according to the random comprehensive sequentialmethod,each group of 25 cases.Group A was given routinewesternmedicine comprehensive treatment.Group B was given Shexiang Baoxin Pills orally on the basis of routine western medicine comprehensive treatment,2 tablets per time,three times per day,used for 10 days.Group C was treated with Ligustrazine 120 mg added into the 250 ml 5%glucose injection or 0.9%sodium chloride injection intravenous drip for 10 days.Group D was treated with Shexiang Baoxin Pills orally,2 tablets per time,three times per day,and combination with Ligustrazine 120mg added into the 250ml 5%glucose injection or 0.9%sodium chloride injection were injected intravenously for 10 days,on the basis of routine Western medicine.The brain natriuretic peptide(BNP),the first second forced expiratory volume ratio (FEV1%),arterial blood oxygen partial pressure(PaO2),arterial blood carbon dioxide partial pressure (PaCO2)and treatment total efficiency before and after treatmentwere compared with the four groups of patients.ResultsAfter treatment,the BNP levels of patients in the A,B,C group were lower than before the treatment,the differenceswere statistically significant(P＜0.05),while therewas no statistically significant difference of patients in group D before and after treatmentwith BNP levels(P＞0.05).The BNP level of group D was higher than that of group A,B and C,and the differences were statistically significant(P＜0.05).After treatment,the FEV1%and PaO2in the four groupswere higher than before treatment,and the differenceswere statistically significant(P＜0.05).After treatment,the FEV1%and PaO2in group D were higher than those in the group A,B and C,and PaCO2was lower than that in the group A,B and C,with statistically significant differences (P＜0.05).The total effective rate of clinical treatment in group D was higher than that in group A,B and C,and the differenceswere statistically significant(P＜0.05).ConclusionShexiang Baoxin Pills combined with Ligustrazine in the treatment of acute exacerbation of chronic pulmonary heart disease has a significanteffect on improving cardiopulmonary function.
万乐乐;易颂刚;敖苏民. 麝香保心丸联合川芎嗪治疗慢性肺源性心脏病急性加重期的效果观察[J]. 中国当代医药, 2018, 25(16): 153-156.
WAN Le-le;YISong-gang;AO Su-min. Effect observation of Shexiang Baoxin Pills combined w ith Ligustrazine in the treatment of acute exacerbation of chronic pulmonary heart disease. 中国当代医药, 2018, 25(16): 153-156.
京公网安备 11010502046607号